Cordys Receives Prestigious NWO Take-off Phase 2 Loan to Launch AI-ECG Pilots Across Europe

Cordys Analytics has been awarded the highly competitive NWO Take-off Phase 2 loan to accelerate the clinical validation and implementation of its AI-powered ECG platform, GALVO, in leading hospitals across Europe.

The loan paves the way for Cordys to initiate commercial pilots across top hospitals in the Netherlands, Spain, Italy, and France. These pilots aim to demonstrate the medical effectiveness of the AI-ECG software, streamline integration into clinical workflows, and build a strong foundation for scaling the platform across Europe.

“This is a major milestone in our mission to bring next-generation AI diagnostics into everyday heart care,” said John van den Berg, CEO of Cordys. “Backed by NWO and strengthened by our recent MDR certification, we are ready to demonstrate the real-world value of our AI technology and drive broader adoption across the European healthcare system.”

The GALVO platform uses deep learning algorithms to detect over 38 heart conditions—including arrhythmias, ischemia, and heart failure—through rapid and accurate interpretation of 12-lead ECGs. Its clinical decision support tools aim to reduce diagnostic delays, lower unnecessary follow-up testing, and support overburdened care teams.

The NWO Take-off Phase 2 loan supports early-stage companies in translating scientific innovations into market-ready solutions. For Cordys, this funding is a critical enabler to attract follow-on investment and expand its impact in the fast-growing field of AI-driven cardiovascular diagnostics.